Remote Ischemic Perconditioning and 90-Day Cognitive Outcomes After Acute Ischemic Stroke: A REMOTE-CAT Substudy
Pereira, C.; REMOTE-CAT Trial Investigators, ; Arque, G.; Regue, A.; Mauri-Capdevila, G.; Jimenez-Fabrega, X.; Subirats, T.; Ropero, J. R.; Vicente-Pascual, M.; Rovira, A.; Salvany, S.; Garcia-Vazquez, C.; Cirer-Sastre, R.; Purroy, F.
Show abstract
Background: Remote ischemic perconditioning (RIperC) is a simple, noninvasive neuroprotective strategy based on brief cycles of limb ischemia-reperfusion during cerebral ischemia. REMOTE-CAT suggested a potential functional benefit of prehospital RIperC in acute ischemic stroke. However, its effect on poststroke cognitive outcomes, which may not be fully captured by global disability scales, remains uncertain. Methods: We performed an exploratory cognitive substudy of the multicenter, randomized, double-blind, sham-controlled REMOTE-CAT trial. Patients with suspected acute ischemic stroke within 8 hours, prestroke modified Rankin Scale score <3, and RACE motor score >0 were randomized prehospital to RIperC or sham. RIperC consisted of five 5-minute cuff inflation-deflation cycles during ambulance transfer. At 90 days, patients from one center underwent a standardized neuropsychological battery assessing five cognitive domains. Results: Among 122 patients in the primary analysis, 58 (47.5%) completed neuropsychological assessment: 26 allocated to RIperC and 32 to sham. No statistically significant between-group differences were observed in domain-specific Z scores. Cognitive impairment in at least one domain was numerically less frequent with RIperC than sham (26.9% versus 34.4%). Impairment in more than one domain was also less frequent with RIperC (7.7% versus 21.9%), although the overall distribution of impaired domains did not differ significantly between groups (P=0.244). The largest domain-specific difference was observed for visual memory impairment (3.8% versus 21.9%). Conclusions: In this exploratory substudy, prehospital RIperC did not significantly improve 90-day cognitive outcomes after acute ischemic stroke. Nevertheless, RIperC-treated patients showed numerically favorable trends, particularly in global cognitive burden and visual memory. These hypothesis-generating findings support incorporating standardized cognitive outcomes in future ischemic conditioning trials.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of Time to Thrombolysis on Clinical Outcomes in Patients with Acute Ischemic Stroke Treated with Tenecteplase Compared to Alteplase: Analysis from the AcT Randomized Controlled Trial 96%
- Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions 96%
- Improvement in Delivery of Ischemic Stroke Treatments but Stagnation of Clinical Outcomes in Young Adults in South Korea 95%
Similar papers in this journal
- Circulating interleukin-6 levels and incident ischemic stroke: a systematic review and meta-analysis of population-based cohort studies 95%
- Adaptive trials in stroke: Current use & future directions 94%
- Lesions in putative language and attention regions are linked to more severe strokes in patients with higher white matter hyperintensity burden 93%
Similar papers in this journal
- Left Hemisphere Bias of NIH Stroke Scale is Most Severe for Middle Cerebral Artery Strokes 95%
- Preliminary outcomes of combined treadmill and overground high-intensity interval training in ambulatory chronic stroke 94%
- Smoking does not alter treatment effect of intravenous thrombolysis in mild to moderate acute ischemic stroke; a Dutch String-of-Pearls Institute (PSI) Stroke Study 94%
Similar papers in this journal
- Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Long-Term Day 90 Outcome 96%
- White matter lesions as a prognostic marker of recurrence in cryptogenic stroke with high-risk patent foramen ovale 94%
- Impact of Fludrocortisone on the Outcomes of Subarachnoid Hemorrhage Patients: A Retrospective Analysis 93%
Similar papers in this journal
- Tenecteplase 0.4 mg/kg in moderate and severe acute ischemic stroke: A pooled analysis of NOR-TEST & NOR-TEST 2A 97%
- COVID-19 Infection Is Associated with Poor Outcomes in Patients with Intracerebral Hemorrhage 96%
- Intravenous Thrombolysis before Thrombectomy Improves Functional Outcome after Stroke Independent of Reperfusion Grade 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.